|
US2951540A
(en)
|
1956-11-05 |
1960-09-06 |
Gen Motors Corp |
Propeller brake
|
|
US3709898A
(en)
|
1971-02-09 |
1973-01-09 |
Upjohn Co |
Process for the production of triazolobenzodiazepines and intermediates
|
|
US3681343A
(en)
|
1971-05-11 |
1972-08-01 |
Upjohn Co |
6-phenyl-s-triazolo{8 4,3-a{9 {8 1,4{9 {0 benzodiazepines
|
|
US3812259A
(en)
|
1971-08-09 |
1974-05-21 |
Upjohn Co |
Animal feed and process
|
|
CH622019A5
(en)
|
1975-10-23 |
1981-03-13 |
Upjohn Co |
Process for the preparation of aminotriazolobenzodiazepines
|
|
FR2329668A1
(fr)
|
1975-10-27 |
1977-05-27 |
Upjohn Co |
Procede de preparation d'aminotriazolobenzodiazepines
|
|
EP0087850A1
(en)
|
1982-01-04 |
1983-09-07 |
The Upjohn Company |
Benzodiazepines for anti-hypertensive use
|
|
DE3435973A1
(de)
|
1984-10-01 |
1986-04-10 |
Boehringer Ingelheim KG, 6507 Ingelheim |
Diazepine enthaltende pharmazeutische zusammensetzungen mit paf-antagonistischer wirkung
|
|
DE3724164A1
(de)
|
1986-07-25 |
1988-01-28 |
Boehringer Ingelheim Kg |
Neue 1,4-benzodiazepine, ihre herstellung und verwendung
|
|
DE3878833T2
(de)
|
1987-05-28 |
1993-06-09 |
Yoshitomi Pharmaceutical |
Thieno(triazolo)diazepinverbindungen, und medizinische verwendung derselben.
|
|
JPH0676326B2
(ja)
|
1988-05-24 |
1994-09-28 |
吉富製薬株式会社 |
循環器系疾患治療薬
|
|
EP0368175A1
(de)
|
1988-11-06 |
1990-05-16 |
Boehringer Ingelheim Kg |
3S,7S-3-(Morpholinocarbonyl)-5-(2-chlorphenyl)-7,10-dimethyl-3,4-dihydro-2H,7H-cyclopenta[4,5]thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin.
|
|
EP0387613A1
(de)
|
1989-03-03 |
1990-09-19 |
Boehringer Ingelheim Kg |
Neue Thienodiazepine
|
|
CA2020806A1
(en)
|
1989-07-12 |
1991-01-13 |
Karl-Heinz Weber |
Thienodiazepine derivatives
|
|
DE4010528A1
(de)
|
1990-04-02 |
1991-10-17 |
Boehringer Ingelheim Kg |
Praeparativ chromatographisches trennverfahren zur herstellung enantiomerenreiner hetrazepine
|
|
EP0638560A4
(en)
|
1991-10-11 |
1995-03-29 |
Yoshitomi Pharmaceutical |
MEDICINE FOR OSTEOPOROSIS AND DIAZEPINE COMPOUND *.
|
|
WO1994006802A1
(fr)
*
|
1992-09-18 |
1994-03-31 |
Yoshitomi Pharmaceutical Industries, Ltd. |
Compose de thienodiazepine et son utilisation medicinale
|
|
CA2159344A1
(en)
|
1993-03-30 |
1994-10-13 |
Minoru Moriwaki |
Cell adhesion inhibitor and thienotriazolodiazepine compound
|
|
WO1995026966A1
(en)
|
1994-04-01 |
1995-10-12 |
Microcide Pharmaceuticals, Inc. |
Cephalosporin antibiotics
|
|
WO1995032963A1
(en)
|
1994-06-01 |
1995-12-07 |
Yoshitomi Pharmaceutical Industries, Ltd. |
Thienylazole compound and thienotriazolodiazepine compound
|
|
JP3001979B2
(ja)
|
1995-01-06 |
2000-01-24 |
エフ・ホフマン−ラ ロシュ アーゲー |
ヒドロキシメチル−イミダゾジアゼピン類及びそれらのエステル
|
|
US5730723A
(en)
|
1995-10-10 |
1998-03-24 |
Visionary Medical Products Corporation, Inc. |
Gas pressured needle-less injection device and method
|
|
CA2230477A1
(en)
|
1995-09-09 |
1997-03-13 |
F. Hoffmann-La Roche Ag |
Use of a thienotriazolodiazepine to increase apolipoprotein a-i levels
|
|
GB9607549D0
(en)
|
1996-04-11 |
1996-06-12 |
Weston Medical Ltd |
Spring-powered dispensing device
|
|
CA2258053A1
(en)
|
1996-06-12 |
1997-12-18 |
Yoshihisa Yamamoto |
Cytokine production inhibitors, triazepine compounds, and intermediates thereof
|
|
US5693641A
(en)
|
1996-08-16 |
1997-12-02 |
Berlex Laboratories Inc. |
Bicyclic pyrimidine derivatives and their use as anti-coagulants
|
|
ATE227727T1
(de)
|
1996-09-13 |
2002-11-15 |
Mitsubishi Pharma Corp |
Thienotriazolodiazepinverbindungen und ihre medizinischen anwendungen
|
|
US6444664B1
(en)
|
1997-04-18 |
2002-09-03 |
Nederlandse Organisatie Voor Toegepast - Natuurweten Schappelijk Onderzoek (Tno) |
Method for controlling the plasma level of lipoproteins to treat alzheimeris disease
|
|
JPH11228576A
(ja)
|
1997-12-10 |
1999-08-24 |
Japan Tobacco Inc |
アポトーシス抑制剤
|
|
IT1298087B1
(it)
|
1998-01-08 |
1999-12-20 |
Fiderm S R L |
Dispositivo per il controllo della profondita' di penetrazione di un ago, in particolare applicabile ad una siringa per iniezioni
|
|
FR2779652B1
(fr)
|
1998-06-15 |
2001-06-08 |
Sod Conseils Rech Applic |
Utilisation de diazepines pour la preparation de medicaments destines a traiter les etats pathologiques ou les maladies dans lesquels un des recepteurs de la somatostatine est implique
|
|
KR20000016732A
(en)
|
1998-12-12 |
2000-03-25 |
Japan Tobacco Inc |
Cytokine production inhibitors, triazepine compounds, and intermediates thereof
|
|
US6312215B1
(en)
|
2000-02-15 |
2001-11-06 |
United Technologies Corporation |
Turbine engine windmilling brake
|
|
US7589167B2
(en)
|
2000-02-22 |
2009-09-15 |
J. David Gladstone Institutes |
ZA loops of bromodomains
|
|
EP1297836A4
(en)
|
2000-06-16 |
2007-06-13 |
Mitsubishi Pharma Corp |
COMPOSITIONS FOR REGULATING THE RANGE AND / OR SPEED OF PH RELEASE
|
|
US6552037B2
(en)
|
2000-06-30 |
2003-04-22 |
Neurogen Corporation |
2-Substituted imidazo[1,2-A]pyridine derivatives
|
|
US20060142257A1
(en)
|
2001-01-19 |
2006-06-29 |
Eberhard Nieschlag |
Male contraceptive formulation comprising norethisterone
|
|
US6979682B2
(en)
|
2001-02-23 |
2005-12-27 |
Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College |
Platelet-activating factor antagonist inhibition of angiogenesis and tumor growth induced by basic fibroblast
|
|
US20030216758A1
(en)
|
2001-12-28 |
2003-11-20 |
Angiotech Pharmaceuticals, Inc. |
Coated surgical patches
|
|
GB0206215D0
(en)
|
2002-03-15 |
2002-05-01 |
Novartis Ag |
Organic compounds
|
|
US6861422B2
(en)
|
2003-02-26 |
2005-03-01 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions
|
|
KR20050106465A
(ko)
|
2003-02-27 |
2005-11-09 |
아보트 러보러터리즈 |
헤테로사이클릭 키나제 억제제
|
|
GB0305929D0
(en)
|
2003-03-14 |
2003-04-23 |
Novartis Ag |
Organic compounds
|
|
WO2005002526A2
(en)
|
2003-07-01 |
2005-01-13 |
President And Fellows Of Harvard College |
Method and compositions for treatment of viral infections
|
|
CN100584832C
(zh)
|
2003-09-18 |
2010-01-27 |
诺瓦提斯公司 |
可用于治疗增殖性病症的2,4-二(苯基氨基)嘧啶类
|
|
EP1528056A1
(en)
|
2003-10-29 |
2005-05-04 |
Academisch Ziekenhuis bij de Universiteit van Amsterdam |
Deoxynojirimycin analogues and their uses as glucosylceramidase inhibitors
|
|
US20060035903A1
(en)
|
2004-08-14 |
2006-02-16 |
Boehringer Ingelheim International Gmbh |
Storage stable perfusion solution for dihydropteridinones
|
|
US7759485B2
(en)
|
2004-08-14 |
2010-07-20 |
Boehringer Ingelheim International Gmbh |
Process for the manufacture of dihydropteridinones
|
|
US20060058311A1
(en)
|
2004-08-14 |
2006-03-16 |
Boehringer Ingelheim International Gmbh |
Combinations for the treatment of diseases involving cell proliferation
|
|
US20060074088A1
(en)
|
2004-08-14 |
2006-04-06 |
Boehringer Ingelheim International Gmbh |
Dihydropteridinones for the treatment of cancer diseases
|
|
CN1759834B
(zh)
|
2004-09-17 |
2010-06-23 |
中国医学科学院医药生物技术研究所 |
黄连素或其与辛伐他汀联合在制备用于预防或治疗与血脂有关疾病或症状的产品中用途
|
|
WO2006129623A1
(ja)
|
2005-05-30 |
2006-12-07 |
Mitsubishi Tanabe Pharma Corporation |
チエノトリアゾロジアゼピン化合物及びその医薬としての用途
|
|
US8604042B2
(en)
|
2005-11-01 |
2013-12-10 |
Targegen, Inc. |
Bi-aryl meta-pyrimidine inhibitors of kinases
|
|
JP5191391B2
(ja)
|
2005-11-01 |
2013-05-08 |
ターゲジェン インコーポレーティッド |
キナーゼのビ−アリールメタ−ピリミジン阻害剤
|
|
US8133900B2
(en)
|
2005-11-01 |
2012-03-13 |
Targegen, Inc. |
Use of bi-aryl meta-pyrimidine inhibitors of kinases
|
|
TW200803842A
(en)
|
2005-11-04 |
2008-01-16 |
Wyeth Corp |
Antineoplastic combinations of temsirolimus and sunitinib malate
|
|
JP5140600B2
(ja)
|
2005-12-23 |
2013-02-06 |
グラクソスミスクライン・リミテッド・ライアビリティ・カンパニー |
オーロラキナーゼのアザインドール阻害薬
|
|
CN101370807B
(zh)
|
2006-01-17 |
2011-08-31 |
弗·哈夫曼-拉罗切有限公司 |
可用于经由gaba受体治疗阿尔茨海默病的芳基-异唑-4-基-咪唑并[1,2-a]吡啶
|
|
NZ570530A
(en)
|
2006-02-14 |
2011-09-30 |
Vertex Pharma |
Pharmaceutical compositions comprising 6-oxo-6,7,8,9-tetrahydro-5H-pyrimido[4,5-b][1,4)diazepine derivatives
|
|
US20070218135A1
(en)
|
2006-03-14 |
2007-09-20 |
Glenmark Pharmaceuticals Limited |
Sustained release matrix pharmaceutical composition
|
|
AU2007248112A1
(en)
|
2006-05-03 |
2007-11-15 |
Novartis Ag |
Use of organic compounds
|
|
US7621117B2
(en)
|
2006-06-19 |
2009-11-24 |
Pratt & Whitney Canada Corp. |
Apparatus and method for controlling engine windmilling
|
|
MX337906B
(es)
|
2006-10-19 |
2016-03-28 |
Signal Pharm Llc |
Compuestos de heteroarilo, composiciones de los mismos, y su uso como inhibidores de proteina cinasas.
|
|
US7624617B2
(en)
|
2006-11-21 |
2009-12-01 |
Asml Netherlands B.V. |
Gas analyzing system, lithographic apparatus and method of improving a sensitivity of a gas analyzing system
|
|
WO2008066887A2
(en)
|
2006-11-30 |
2008-06-05 |
Albert Einstein College Of Medicine Of Yeshiva University |
Small molecule inhibitors of bcl6
|
|
JP2008156311A
(ja)
|
2006-12-26 |
2008-07-10 |
Institute Of Physical & Chemical Research |
Ｂｒｄ２ブロモドメイン結合剤
|
|
WO2008137081A1
(en)
|
2007-05-02 |
2008-11-13 |
The Trustees Of Columbia University In The City Of New York |
Substituted ( 5, 6 ) -dihydronaphraalenyl compounds as reversible male contraceptives
|
|
KR20080107050A
(ko)
|
2007-06-05 |
2008-12-10 |
울산대학교 산학협력단 |
항-ｃｄ１３７ 단일클론 항체를 포함하는 만성이식편대숙주 질환의 예방 또는 치료용 약학적 조성물
|
|
WO2009080638A2
(en)
|
2007-12-20 |
2009-07-02 |
Cellzome Limited |
Sulfamides as zap-70 inhibitors
|
|
KR101600634B1
(ko)
|
2007-12-28 |
2016-03-07 |
미쓰비시 타나베 파마 코퍼레이션 |
항암제
|
|
WO2009112490A1
(en)
|
2008-03-11 |
2009-09-17 |
Cellzome Limited |
Sulfonamides as zap-70 inhibitors
|
|
USPP20436P2
(en)
|
2008-04-10 |
2009-10-20 |
Driscoll Strawberry Associates, Inc. |
Blueberry plant named ‘DrisBlueThree’
|
|
WO2010015340A1
(en)
|
2008-08-06 |
2010-02-11 |
Bayer Schering Pharma Aktiengesellschaft |
Daa-pyridine as peripheral benzodiazepine receptor ligand for diagnostic imaging and pharmaceutical treatment
|
|
CA2741934C
(en)
|
2008-10-30 |
2016-09-13 |
Circomed Llc |
Thienotriazolodiazepine derivatives active on apo a
|
|
EP3828185B1
(en)
|
2009-01-06 |
2024-11-20 |
Dana-Farber Cancer Institute, Inc. |
Pyrimido-diazepinone kinase scaffold compounds and methods of treating disorders
|
|
BRPI1007358A2
(pt)
|
2009-01-23 |
2018-03-06 |
Takeda Pharmaceutical Company Limited |
inibidores de poli (adp-ribose) polimerase (parp)
|
|
WO2011054644A1
(en)
|
2009-10-14 |
2011-05-12 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
A low density lipoprotein-related protein 1 splice variant as cancer marker
|
|
GB0919434D0
(en)
|
2009-11-05 |
2009-12-23 |
Glaxosmithkline Llc |
Novel compounds
|
|
GB0919432D0
(en)
|
2009-11-05 |
2009-12-23 |
Glaxosmithkline Llc |
Use
|
|
CN102781943B
(zh)
|
2009-11-05 |
2016-10-05 |
葛兰素史密丝克莱恩有限责任公司 |
苯并二氮杂*溴结构域抑制剂
|
|
NZ599258A
(en)
|
2009-11-05 |
2014-05-30 |
Glaxosmithkline Llc |
Benzodiazepine bromodomain inhibitor
|
|
GB0919423D0
(en)
|
2009-11-05 |
2009-12-23 |
Glaxosmithkline Llc |
Novel compounds
|
|
DE102009046518A1
(de)
|
2009-11-09 |
2011-05-12 |
Robert Bosch Gmbh |
Speicheranordnung
|
|
WO2011101369A1
(en)
|
2010-02-17 |
2011-08-25 |
Boehringer Ingelheim International Gmbh |
Dihydropteridinones, method for production and use thereof
|
|
EP2553251B1
(en)
|
2010-03-26 |
2018-11-07 |
Rolls-Royce North American Technologies, Inc. |
Adaptive fan system for a variable cycle turbofan engine
|
|
WO2011143651A1
(en)
|
2010-05-14 |
2011-11-17 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for modulating metabolism
|
|
BR122014024883A2
(pt)
|
2010-05-14 |
2019-08-20 |
Dana-Farber Cancer Institute, Inc. |
Compostos no tratamento de neoplasia
|
|
CN103154246B
(zh)
|
2010-05-14 |
2015-11-25 |
达那-法伯癌症研究所 |
用于治疗白血病的组合物和方法
|
|
US9301962B2
(en)
|
2010-05-14 |
2016-04-05 |
Baylor College Of Medicine |
Male contraceptive compositions and methods of use
|
|
ES2526671T3
(es)
|
2010-06-22 |
2015-01-14 |
Glaxosmithkline Llc |
Compuestos de benzotriazoldiazepina inhibidores de bromodominios
|
|
US9320711B2
(en)
|
2010-06-25 |
2016-04-26 |
Shire Human Genetic Therapies, Inc. |
Methods and compositions for CNS delivery of heparan N-sulfatase
|
|
US20120014979A1
(en)
|
2010-07-16 |
2012-01-19 |
Alexander Dent |
Use of bcl6 inhibitors for treating autoimmune diseases
|
|
TWI583689B
(zh)
|
2010-08-04 |
2017-05-21 |
達納 法柏癌症學院有限公司 |
治療腫瘤形成、發炎疾病及其他病症之組成物及方法
|
|
DK2621282T3
(da)
|
2010-09-28 |
2020-05-04 |
Univ California |
Gaba-agonister i behandlingen af forstyrrelser forbundet med metabolisk syndrom og gaba-kombinationer i behandling eller profylakse af type i diabetes
|
|
AR084070A1
(es)
|
2010-12-02 |
2013-04-17 |
Constellation Pharmaceuticals Inc |
Inhibidores del bromodominio y usos de los mismos
|
|
WO2012075456A1
(en)
|
2010-12-02 |
2012-06-07 |
Constellation Pharmaceuticals |
Bromodomain inhibitors and uses thereof
|
|
CN103547152A
(zh)
|
2011-02-23 |
2014-01-29 |
西奈山伊坎医学院 |
溴结构域蛋白的抑制剂作为基因表达的调节剂
|
|
EP2681216B1
(en)
|
2011-02-28 |
2017-09-27 |
Epizyme, Inc. |
Substituted 6,5-fused bicyclic heteroaryl compounds
|
|
WO2013019710A1
(en)
|
2011-07-29 |
2013-02-07 |
The Children's Hospital Of Philadelphia |
Compositions and methods for the treatment of hiv
|
|
WO2013033269A1
(en)
|
2011-08-29 |
2013-03-07 |
Coferon, Inc. |
Bioorthogonal monomers capable of dimerizing and targeting bromodomains and methods of using same
|
|
FI20110279A7
(fi)
|
2011-08-29 |
2013-03-01 |
Outotec Oyj |
Menetelmä metallien talteenottamiseksi niitä sisältävästä materiaalista
|
|
WO2013033270A2
(en)
|
2011-08-29 |
2013-03-07 |
Coferon, Inc. |
Bromodomain ligands capable of dimerizing in an aqueous solution, and methods of using same
|
|
US10071129B2
(en)
|
2011-08-30 |
2018-09-11 |
Whitehead Institute For Biomedical Research Dana-Farber Cancer Institute, Inc. |
Method for identifying bromodomain inhibitors
|
|
DE102011082013A1
(de)
*
|
2011-09-01 |
2013-03-07 |
Bayer Pharma AG |
6H-Thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine
|
|
WO2013097052A1
(en)
|
2011-12-30 |
2013-07-04 |
Abbott Laboratories |
Bromodomain inhibitors
|
|
CN109529026A
(zh)
|
2012-02-17 |
2019-03-29 |
安迅生物制药公司 |
用于治疗流感和副流感患者的方法、化合物和组合物
|
|
US20150133434A1
(en)
|
2012-03-28 |
2015-05-14 |
The J. David Gladstone Institutes |
Compositions and Methods for Reactivating Latent Immunodeficiency Virus
|
|
WO2013192274A2
(en)
|
2012-06-19 |
2013-12-27 |
The Broad Institute, Inc. |
Diagnostic and treatment methods in subjects having or at risk of developing resistance to cancer therapy
|
|
US20140107107A1
(en)
*
|
2012-09-28 |
2014-04-17 |
Oncoethix Sa |
Pharmaceutical formulation containing thienotriazolodiazepine compounds
|
|
US9567301B2
(en)
|
2012-11-02 |
2017-02-14 |
Dana-Farber Cancer Institute, Inc. |
Pyrrol-1-yl benzoic acid derivatives useful as myc inhibitors
|
|
HK1212345A1
(en)
|
2013-02-22 |
2016-06-10 |
Bayer Pharma Aktiengesellschaft |
4-substituted pyrrolo- and pyrazolo-diazepines
|
|
CA2901799A1
(en)
|
2013-02-22 |
2014-08-28 |
Bayer Pharma Aktiengesellschaft |
Pyrrolo- and pyrazolo-triazolodiazepines as bet-protein inhibitors for treating hyperproliferative diseases
|
|
EP2961411A4
(en)
*
|
2013-02-28 |
2016-11-23 |
Univ Washington |
METHOD FOR TREATING INFECTIONS WITH HUMAN CYTOMAL GALOVIRUS AND DISEASES WITH BROMDOMAIN DISEASES
|
|
WO2014159392A1
(en)
*
|
2013-03-14 |
2014-10-02 |
Dana-Farber Cancer Institute, Inc. |
Bromodomain binding reagents and uses thereof
|
|
JP2016519672A
(ja)
|
2013-03-15 |
2016-07-07 |
ジェネンテック， インコーポレイテッド |
ブロモドメイン含有タンパク質ｂｒｄ７およびｂｒｄ９の阻害によるｔｈ２媒介性疾患の治療
|
|
US20160095867A1
(en)
|
2013-05-28 |
2016-04-07 |
Dana-Farber Cancer Institute, Inc. |
Bet inhibition therapy for heart disease
|
|
EP3024327B1
(en)
|
2013-07-25 |
2019-09-04 |
Dana-Farber Cancer Institute, Inc. |
Inhibitors of transcription factors and uses thereof
|
|
WO2015018522A1
(en)
|
2013-08-06 |
2015-02-12 |
Oncoethix Sa |
Bet-bromodomain inhibitor shows synergism with several anti-cancer agents in pre-clinical models of diffuse large b-cell lymphoma (dlbcl)
|
|
EP3030242A1
(en)
|
2013-08-06 |
2016-06-15 |
Oncoethix GmbH |
Method of treating diffuse large b-cell lymphoma (dlbcl) using a bet-bromodomain inhibitor
|
|
EP3033423A4
(en)
|
2013-08-16 |
2017-04-26 |
Rana Therapeutics Inc. |
Epigenetic regulators of frataxin
|
|
CA2922503C
(en)
|
2013-09-19 |
2021-10-26 |
Dana-Farber Cancer Institute, Inc. |
Methods of bh3 profiling
|
|
EP3054966A4
(en)
|
2013-10-11 |
2017-04-19 |
Genentech, Inc. |
Use of cbp/ep300 bromodomain inhibitors for cancer immunotherapy
|
|
EP3066101B1
(en)
|
2013-11-08 |
2020-07-29 |
Dana-Farber Cancer Institute, Inc. |
Combination therapy for cancer using bromodomain and extra-terminal (bet) protein inhibitors
|
|
WO2015081284A1
(en)
|
2013-11-26 |
2015-06-04 |
Coferon, Inc. |
Bivalent bromodomain ligands, and methods of using same
|
|
WO2015117083A1
(en)
|
2014-01-31 |
2015-08-06 |
Dana-Farber Cancer Institute, Inc. |
Diazepane derivatives and uses thereof
|
|
RU2016134947A
(ru)
|
2014-01-31 |
2018-03-01 |
Дана-Фарбер Кансер Институт, Инк. |
Производные диаминопиримидин бензолсульфона и их применение
|
|
WO2015117087A1
(en)
|
2014-01-31 |
2015-08-06 |
Dana-Farber Cancer Institute, Inc. |
Uses of diazepane derivatives
|
|
MX377534B
(es)
|
2014-02-28 |
2025-03-10 |
Tensha Therapeutics Inc |
Compuestos para usarse en el tratamiento de hiperinsulinemia.
|
|
US10124009B2
(en)
|
2014-10-27 |
2018-11-13 |
Tensha Therapeutics, Inc. |
Bromodomain inhibitors
|
|
KR20170101913A
(ko)
|
2014-12-05 |
2017-09-06 |
에이치 리 모피트 캔서 센터 앤드 리서어치 인스티튜트 아이엔씨 |
암 면역치료의 보조제로서의 브로모도메인 억제제
|
|
US20180193350A1
(en)
|
2015-06-26 |
2018-07-12 |
Tensha Therapeutics, Inc. |
Treatment of nut midline carcinoma
|
|
KR20180081507A
(ko)
|
2015-10-02 |
2018-07-16 |
다나-파버 캔서 인스티튜트 인크. |
브로모도메인 저해제와 관문 차단의 조합 요법
|